P412: LOW EXPOSURE, EXTENDED DOSING MIMICKING CLINICAL EXPOSURES OF ORAL AZACITIDINE SYNERGIZES WITH VENETOCLAX IN PRECLINICAL AML MODELS. (23rd June 2022) - Jeyaraju, D.; Alapa, M.; Polonskaia, A.; Risueno Perez, A.; Hurren, R.; Wang, X.; Gronda, M.; Ahsan, A.; Wang, C.; Subramanyam, P.; Sriganesh, J.; Anand, A.; et al.